2809 Results (Page 1 of 235)
Pharmaceuticals Markets Research Reports
China Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics Market Analysis
China's Paroxysmal Nocturnal Hemoglobinuria (PNH) therapeutics market is expected to grow from $297 Mn in 2022 to $721 Mn in 2030 with a CAGR of 11.70% for the year 2022-30. Since eculizumab, a drug used to treat PNH is now available in China, many patients are starting to express interest in using targeted therapy to treat rare diseases. The market for PNH therapies in China is anticipated to increase as a result of this tendency. The market is segmented by therapy, diagnostic test, and distribution channels. Some key players in this market include Sinopharm Group, Shanghai Pharmaceuticals, Jiangsu Hengrui Medicine, Amgen, CSL Behring, and Bioverativ.
India Retail Pharmacy Market Analysis
India's retail pharmacy market is projected to grow from $18.89 Bn in 2022 to $40.19 Bn by 2030, registering a CAGR of 9.9% during the forecast period of 2022-2030. India's economic growth also contributes to market growth, as a growing economy leads to increased disposable income and investment in healthcare services. The retail pharmacy market in India is highly competitive, with several large players dominating the market, including Apollo Pharmacy, Medplus, and Healthkart.
Malaysia Retail Pharmacy Market Analysis
This report presents a strategic analysis of the Malaysia retail pharmacy market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Malaysia Retail Pharmacy Market, offering unmatched value, accuracy and expert insights.
Nigeria ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Nigeria's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $27 Mn in 2022 to $51 Mn in 2030 with a CAGR of 8.5% for the year 2022-2030. The major factors responsible for the expansion of the market in Nigeria include increasing awareness about ADHD and consequently the demand for its therapeutic options. The Nigeria ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Phamatex, LaBeta drugs, and Eli Lilly are the key players in the market.
Malaysia Pharmaceutical Market Analysis
This report presents a strategic analysis of the Malaysia pharmaceutical market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Malaysia Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
UK Women's Health Market Analysis
In the UK, the National Health Service (NHS) provides free medical care to women, as a result, the market size of UK women’s health is predicted to witness an upsurge of about $537 Mn in 2022 with a CAGR of 5.5% and is estimated to reach $824 Mn in 2030. Growing female labour force participation, particularly in the UK, has made a substantial contribution to the market's expansion. The market is segmented by product type and by disease type. Amgen, Allergen, and Merck and Co. are some of the leading players in the women’s health market.
India Women's Health Market Analysis
India's women’s health market is projected to grow from $0.726 Bn in 2022 to $1.325 Bn by 2030, registering a CAGR of 7.80% during the forecast period of 2022-2030. The increasing number of working women in India is driving the women's health market as they have more disposable income and need health care services. Some key players in the India Women's Health market include Apollo Hospitals, Manipal, and Medanta.
Canada Pharmaceutical Market Analysis
Canada's pharmaceutical market size is about $83.08 Bn in 2022 and is expected to witness significant growth of about $141.69 Bn in 2030 with a CAGR of 6.9% as there are a large number of overseas pharmaceutical companies having a presence in Canada. The incidences of chronic diseases among the Canadian population and comorbidities associated with the diseases are likely to positively impact the growth of the pharmaceutical market over the forecast period. The market is segmented by formulation type, route of administration type and prescription type, etc. Some of the leading players in the market are Pfizer, Novartis AG, and Roche.
India Dialysis Market Analysis
India's dialysis market is projected to grow from $2.113 Bn in 2022 to $4.368 Bn by 2030, registering a CAGR of 9.50% during the forecast period of 2022 to 2030. The incidence of chronic kidney disease in India is on the rise due to factors such as diabetes and hypertension, which are becoming more prevalent in the country. This is driving the demand for dialysis treatment. Fresenius Medical Care is one of the leading players in the market, with a wide range of dialysis products and services, including hemodialysis machines, dialysis concentrates, and dialysis services.
India Dermatology Drugs Market Analysis
By 2030, it is anticipated that India's dermatology drugs market will reach a value of $870 Mn from $309 Mn in 2022, growing at a CAGR of 13.8% during 2022-30. The dermatology drug market in India is dominated by a few large pharmaceutical companies such as Vibcare Pharma Zee Laboratories and Sun Pharmaceutical Industries Limited. The dermatology drug market in India is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel. The major factors affecting the Indian dermatology drugs market are the increasing disease burden of non-communicable diseases, the lack of a proper reimbursement process, and the high cost of drugs.
India Oncology Drugs Market Analysis
By 2030, it is anticipated that the India oncology drugs market will reach a value of $10.6 Bn from $3.6 Bn in 2022 and is expected to grow at a CAGR of 14.6% during 2022-30. The companies operating in the oncology drug in India market are Roche Diagnostics, Novartis Oncology and Celgene Corporation. This market is segmented on the basis of therapy modality and types of cancer. Factors such as increased awareness about cancer and its treatments, rising disposable incomes, and improved access to healthcare are some of the major drivers of growth in the Indian oncology drug market.
Australia Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics Market Analysis
Australia's Paroxysmal Nocturnal Hemoglobinuria (PNH) therapeutics market is expected to grow from $44 Mn in 2022 to $108 Mn in 2030 with a CAGR of 11.70% for the year 2022-2030. The therapeutic choices available to patients have considerably improved as a result of recent developments in the development of targeted medicines for PNH in Australia, such as complement inhibitors. The market is segmented by therapy, diagnostic test, by distribution channel. Some key players in this market include Mayne Pharma, Mesoblast, Alexion Pharmaceuticals, Alnylam Pharmaceuticals, Akari Therapeutics, Amgen, CSL Behring, and Bioverativ.
Tanzania Radiotherapy Market Analysis
The Radiotherapy Therapeutics Market in Tanzania is dominated by a few domestic players such as Ocean Road Cancer Institute, Varian Medical Systems, and Siemens. The radiotherapy market in Tanzania is segmented into different types, technology, procedures, application, and end-user. The significant risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives and reimbursement policy. The demand for Tanzania Radiotherapy is increasing due to the rise in cancer cases in the country.
Romania Radiotherapy Market Analysis
By 2030, it is anticipated that the Romania Radiotherapy Market will reach a value of $xx Mn from $20 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The Radiotherapy Therapeutics Market in Romania is dominated by a few domestic players such as Rotablator, Nuclearelectrica, and Radon Medical Services. The radiotherapy market in Romania is segmented into different types, technology, procedures, application, and end-user. The significant risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives and reimbursement policy. The demand for Romania Radiotherapy is increasing due to the rise in cancer cases in the country.
Poland Radiotherapy Market Analysis
By 2030, it is anticipated that the Poland Radiotherapy Market will reach a value of $xx Mn from $40 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The Radiotherapy Therapeutics Market in Poland is dominated by a few domestic players such as Elekta Poland, Sun-Nuclear Poland, and Mirion Technologies Poland. The radiotherapy market in Poland is segmented into different types, technology, procedures, application, and end-user. The significant risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives and reimbursement policy. The demand for Poland Radiotherapy is increasing due to the rise in cancer cases in the country.
Nigeria Radiotherapy Market Analysis
By 2030, it is anticipated that the Nigeria Radiotherapy Market will reach a value of $xx Mn from $6 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The Radiotherapy Therapeutics Market in Nigeria is dominated by a few domestic players such as Accuray, Varian Medical Systems, and Siemens. The radiotherapy market in Nigeria is segmented into different types, technology, procedures, application, and end-user. The significant risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives and reimbursement policy. The demand for Nigeria Radiotherapy is increasing due to the rise in cancer cases in the country.
Netherlands Radiotherapy Market Analysis
By 2030, it is anticipated that the Netherlands Radiotherapy Market will reach a value of $xx Mn from $18 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The Radiotherapy Therapeutics Market in the Netherlands is dominated by a few domestic players such as Research Laboratories BV, Philips Healthcare, and Elekta BV. The radiotherapy market in the Netherlands is segmented into different types, technology, procedures, application, and end-user. The significant risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives and reimbursement policy. The demand for Netherlands Radiotherapy is increasing due to the rise in cancer cases in the country.
Belgium Radiotherapy Market Analysis
By 2030, it is anticipated that the Belgium Radiotherapy Market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-2030. The Radiotherapy Therapeutics Market in Belgium is dominated by domestic players such as IBA, Elekta Belgium, and RaySearch Laboratories. The radiotherapy market in Belgium is segmented into different types, technology, procedures, application, and end-user. The significant risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives and reimbursement policy. The demand for Belgium Radiotherapy is increasing due to the rise in cancer cases in the country.
Egypt Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Analysis
Egypt's Chronic Obstructive Pulmonary Disease (COPD) therapeutics market was valued at $51 Mn in 2022 and is estimated to expand at a CAGR of 8.6% from 2022 to 2030 and will reach $99 Mn in 2030. One of the main reasons propelling the growth of this market is government initiatives, Aging population. The market is segmented by Drug class and By distribution channel. Some key players in this market are EIPICO, Pharco, Amoun, Memphis Pharmaceutical, Eva Pharma, Almirall, Astellas Pharma, American Hospital of Paris, Boehringer Ingelheim Pharmaceuticals, Novartis, Pfizer, and others.
Vietnam Radiotherapy Market Analysis
By 2030, it is anticipated that the Vietnam Radiotherapy Market will reach a value of $xx Mn from $35 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The Radiotherapy Therapeutics Market in Vietnam is dominated by a few domestic players such as Viet Medical Equipment, Shimadzu Vietnam, and Varian Medical Systems. The radiotherapy market in Vietnam is segmented into different types, technology, procedures, application, and end-user. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives and reimbursement policy. The demand for Vietnam Radiotherapy is increasing on account of the rise in cancer cases in the country.
UAE Radiotherapy Market Analysis
By 2030, it is anticipated that the UAE Radiotherapy Market will reach a value of $59 Mn from $35 Mn in 2022, growing at a CAGR of 7% during 2022-2030. The Radiotherapy Therapeutics Market in UAE is dominated by a few domestic players such as Elekta, IBA Proton Therapy, and Elekta. The radiotherapy market in UAE is segmented into different types, technology, procedures, application, and end-user. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives and reimbursement policy. The demand for UAE Radiotherapy is increasing on account of the rise in cancer cases in the country.
Turkey Radiotherapy Market Analysis
By 2030, it is anticipated that the Turkey Radiotherapy Market will reach a value of $91 Mn from $55 Mn in 2022, growing at a CAGR of 6.5% during 2022-2030. The Radiotherapy Therapeutics Market in Turkey is dominated by a few domestic players such as Tecnologia en Radioterapia, Medical Plus, and Grupo Gamma. The radiotherapy market in Turkey is segmented into different types, technology, procedures, application, and end-user. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives and reimbursement policy. The demand for Turkey Radiotherapy is increasing on account of the rise in cancer cases in the country.
Thailand Radiotherapy Market Analysis
By 2030, it is anticipated that the Thailand Radiotherapy Market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-2030. The Radiotherapy Therapeutics Market in Thailand is dominated by a few domestic players such as Bangkok Medical Supply, OTO-Medical, and Thai Radiology Equipment. The radiotherapy market in Thailand is segmented into different types, technology, procedures, application, and end-user. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives and reimbursement policy. The demand for Thailand Radiotherapy is increasing on account of the rise in cancer cases in the country.
South Korea Radiotherapy Market Analysis
By 2030, it is anticipated that the South Korea Radiotherapy Market will reach a value of $173 Mn from $101 Mn in 2022, growing at a CAGR of 7% during 2022-2030. The Radiotherapy Therapeutics Market in South Korea is dominated by a few domestic players such as HANRAY, Dongbang Medical, and Neusoft Medical Systems Korea. The radiotherapy market in South Korea is segmented into different types, technology, procedures, application, and end-user. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives and reimbursement policy. The demand for South Korea Radiotherapy is increasing on account of the rise in cancer cases in the country.
South Africa Radiotherapy Market Analysis
By 2030, it is anticipated that the South Africa Radiotherapy Market will reach a value of $xx Mn from $45 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The Radiotherapy Therapeutics Market in South Africa is dominated by a few domestic players such as Acceletronics, Medequip, and Oncovision. The radiotherapy market in South Africa is segmented into different types, technology, procedures, application, and end-user. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives and reimbursement policy. The demand for South Africa Radiotherapy is increasing on account of the rise in cancer cases in the country.